COVID-19 mRNAワクチンによる障害報告のレビュー：リンパ節症

Dr Mark Trozzi（マーク・トロッツィ博士）がCOVID-19 mRNAワクチンによる障害報告に関する査読済み論文の約1,000件を掲載したサイトを作っています。

1000 peer reviewed articles on “Vaccine” injuries

その中で7番目に多くの件数が報告されている「リンパ節症（Lymphadenopathy）」の論文リストを転載させていただきます。

リンパ節症： 片側性、鎖骨上および頸部。リンパ節の大きさに影響を及ぼす疾患。
XBBワクチン接種後に首が痛くなる例が増えているようです。ご注意ください。
血液検査では白血球数が増加し、炎症反応CRPが上がります。
リンパ節では、リンパ液から損傷した細胞、がん細胞、異物がこし取られます。リンパ節内の特殊な白血球は、損傷した細胞、がん細胞、感染性微生物、異物などを飲み込んで破壊します。
痛み、圧痛、発赤をいずれも伴わないリンパ節の腫れは、 リンパ腫、 結核、 ホジキンリンパ腫など、別の重篤な病気の症状である可能性もあります。

掲載論文数: 35

Rare case of contralateral supraclavicular lymphadenopathy after vaccination with COVID-19: computed tomography and ultrasound findings: 
https://pubmed.ncbi.nlm.nih.gov/34667486/

COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET / CT: 
https://pubmed.ncbi.nlm.nih.gov/33591026/

Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients: 
https://pubmed.ncbi.nlm.nih.gov/33625300/

Hypermetabolic lymphadenopathy after administration of BNT162b2 mRNA vaccine Covid-19: incidence assessed by [ 18 F] FDG PET-CT and relevance for study interpretation: 
https://pubmed.ncbi.nlm.nih.gov/33774684/

Lymphadenopathy after COVID-19 vaccination: review of imaging findings: 
https://pubmed.ncbi.nlm.nih.gov/33985872/

Lymphadenopathy associated with COVID-19 vaccination on FDG PET/CT: distinguishing features in adenovirus-vectored vaccine: 
https://pubmed.ncbi.nlm.nih.gov/34115709/
.
COVID-19 vaccination-induced lymphadenopathy in a specialized breast imaging clinic in Israel: analysis of 163 cases: 
https://pubmed.ncbi.nlm.nih.gov/34257025/

Coronavirus disease vaccine 2019 mimics lymph node metastases in patients undergoing skin cancer follow-up: a single-center study: 
https://pubmed.ncbi.nlm.nih.gov/34280870/

COVID-19 post-vaccination lymphadenopathy: report offine-needle aspiration biopsy cytologic findings: 
https://pubmed.ncbi.nlm.nih.gov/34432391/

Regional lymphadenopathy after COVID-19 vaccination: review of the literature and considerations for patient management in breast cancer care: 
https://pubmed.ncbi.nlm.nih.gov/34731748/

Adverse events of COVID injection that may occur in children.Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021: 
https://pubmed.ncbi.nlm.nih.gov/33706861/

Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: 
https://pubmed.ncbi.nlm.nih.gov/34116295/

Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDGfinding: 
https://pubmed.ncbi.nlm.nih.gov/33661328/

A case of cervical lymphadenopathy following COVID-19 vaccination: 
https://pubmed.ncbi.nlm.nih.gov/34141500/

Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties: 
https://pubmed.ncbi.nlm.nih.gov/33713605/

Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic: 
https://pubmed.ncbi.nlm.nih.gov/33685772/

COVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinic: a follow-up audit: 
https://pubmed.ncbi.nlm.nih.gov/33947605/
.
Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services: 
https://pubmed.ncbi.nlm.nih.gov/34526175/

Lymphadenopathy associated with the COVID-19 vaccine: 
https://pubmed.ncbi.nlm.nih.gov/33786231/

Evolution of lymphadenopathy on PET/MRI
Massive cervical lymphadenopathy following vaccination with COVID-19 
https://pubmed.ncbi.nlm.nih.gov/34601889/

Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021:
https://pubmed.ncbi.nlm.nih.gov/33706861/

Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: 
https://pubmed.ncbi.nlm.nih.gov/34116295/

Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDGfinding: 
https://pubmed.ncbi.nlm.nih.gov/33661328/

A case of cervical lymphadenopathy following COVID-19 vaccination: 
https://pubmed.ncbi.nlm.nih.gov/34141500/

Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties: 
https://pubmed.ncbi.nlm.nih.gov/33713605/

Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic: 
https://pubmed.ncbi.nlm.nih.gov/33685772/

COVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinic: a follow-up audit: 
https://pubmed.ncbi.nlm.nih.gov/33947605/

Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services: 
https://pubmed.ncbi.nlm.nih.gov/34526175/

Lymphadenopathy associated with the COVID-19 vaccine: 
https://pubmed.ncbi.nlm.nih.gov/33786231/

Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination: 
https://pubmed.ncbi.nlm.nih.gov/33625301/
.
Massive cervical lymphadenopathy following vaccination with COVID-19 
https://pubmed.ncbi.nlm.nih.gov/34601889/

COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imagingfindings on MRI, CT and PET-CT: 
https://pubmed.ncbi.nlm.nih.gov/34719892/

Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: 
https://pubmed.ncbi.nlm.nih.gov/34116295/
.
Evolution of Lymphadenopathy at Pet/MRI after COVID-19 vaccination:
https://pubmed.ncbi.nlm.nih.gov/33625301/